Patients, Prescribing & Personalised Pharmacy: Innovations and Opportunities

Claudia Pagliari

doi:10.13140/RG.2.2.13196.51848

Patients, Prescribing & Personalised Pharmacy: Innovations and Opportunities

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract / Description of output

This invited talk, given as part of the UK Farr Institute's "Frontiers in Health Informatics Research" series, aimed to introduce public health leaders from academia and government to emerging opportunities at the intersection of pharmaceutical research and digital health. Reflecting on industry trends, and delivered shortly after the launch of Apple’s ResearchKit, it highlighted the potential of innovations such as crowdsourced trial recruitment, mobile outcome measurement, and new generation wearables and ‘insidables’, to improve patient participation and generate real-time, ecologically valid data. The potential of the 'Digital Phenotype' to accelerate the pace of personalised and precision medicine was also examined, as well as some of the ethical challenges involved.

Original language	English
Title of host publication	ResearchGate
Number of pages	16
DOIs	https://doi.org/10.13140/RG.2.2.13196.51848
Publication status	Published - Jun 2015
Event	Farr Institute. Frontiers in Health Informatics Series - Farr Institute for Health Informatics Research, Edinburgh, United Kingdom Duration: 30 Jun 2015 → 30 Jun 2015

Workshop

Workshop	Farr Institute. Frontiers in Health Informatics Series
Country/Territory	United Kingdom
City	Edinburgh
Period	30/06/15 → 30/06/15

Keywords / Materials (for Non-textual outputs)

Digital Health
Pharmaceutical Industry
Research
Patient involvement
Personalised Medicine

Access to Document

10.13140/RG.2.2.13196.51848Licence: Unspecified

Patients, Prescribing & Personalised Pharmacy: Innovations and OpportunitiesLicence: Unspecified

Ethics and Governance of Digital Health
Pagliari, C.
1/01/05 → 1/12/30
Project: Research

1 Types of Business and Community - Continuing Professional Development (CPD)/Training

NHS Digital Academy Module on Citizen-Centred Digital Health
Claudia Pagliari (Lecturer)
2018 → …
Activity: Other activity types › Types of Business and Community - Continuing Professional Development (CPD)/Training

Cite this

@inproceedings{a52d621271c94b00a9a42fbe564f41a4,

title = "Patients, Prescribing & Personalised Pharmacy: Innovations and Opportunities",

abstract = "This invited talk, given as part of the UK Farr Institute's {"}Frontiers in Health Informatics Research{"} series, aimed to introduce public health leaders from academia and government to emerging opportunities at the intersection of pharmaceutical research and digital health. Reflecting on industry trends, and delivered shortly after the launch of Apple{\textquoteright}s ResearchKit, it highlighted the potential of innovations such as crowdsourced trial recruitment, mobile outcome measurement, and new generation wearables and {\textquoteleft}insidables{\textquoteright}, to improve patient participation and generate real-time, ecologically valid data. The potential of the 'Digital Phenotype' to accelerate the pace of personalised and precision medicine was also examined, as well as some of the ethical challenges involved.",

keywords = "Digital Health, Pharmaceutical Industry, Research, Patient involvement, Personalised Medicine",

author = "Claudia Pagliari",

year = "2015",

month = jun,

doi = "10.13140/RG.2.2.13196.51848",

language = "English",

booktitle = "ResearchGate",

note = "Farr Institute. Frontiers in Health Informatics Series ; Conference date: 30-06-2015 Through 30-06-2015",

}

TY - GEN

T1 - Patients, Prescribing & Personalised Pharmacy: Innovations and Opportunities

AU - Pagliari, Claudia

PY - 2015/6

Y1 - 2015/6

N2 - This invited talk, given as part of the UK Farr Institute's "Frontiers in Health Informatics Research" series, aimed to introduce public health leaders from academia and government to emerging opportunities at the intersection of pharmaceutical research and digital health. Reflecting on industry trends, and delivered shortly after the launch of Apple’s ResearchKit, it highlighted the potential of innovations such as crowdsourced trial recruitment, mobile outcome measurement, and new generation wearables and ‘insidables’, to improve patient participation and generate real-time, ecologically valid data. The potential of the 'Digital Phenotype' to accelerate the pace of personalised and precision medicine was also examined, as well as some of the ethical challenges involved.

AB - This invited talk, given as part of the UK Farr Institute's "Frontiers in Health Informatics Research" series, aimed to introduce public health leaders from academia and government to emerging opportunities at the intersection of pharmaceutical research and digital health. Reflecting on industry trends, and delivered shortly after the launch of Apple’s ResearchKit, it highlighted the potential of innovations such as crowdsourced trial recruitment, mobile outcome measurement, and new generation wearables and ‘insidables’, to improve patient participation and generate real-time, ecologically valid data. The potential of the 'Digital Phenotype' to accelerate the pace of personalised and precision medicine was also examined, as well as some of the ethical challenges involved.

KW - Digital Health

KW - Pharmaceutical Industry

KW - Research

KW - Patient involvement

KW - Personalised Medicine

U2 - 10.13140/RG.2.2.13196.51848

DO - 10.13140/RG.2.2.13196.51848

M3 - Conference contribution

BT - ResearchGate

T2 - Farr Institute. Frontiers in Health Informatics Series

Y2 - 30 June 2015 through 30 June 2015

ER -

Patients, Prescribing & Personalised Pharmacy: Innovations and Opportunities

Abstract / Description of output

Workshop

Keywords / Materials (for Non-textual outputs)

Access to Document

Fingerprint

Projects

Ethics and Governance of Digital Health

Activities

NHS Digital Academy Module on Citizen-Centred Digital Health

Cite this